University of Pittsburgh Cancer Institute (UPCI)

CCSG Acknowledgement

Required CCSG Acknowledgement

The NCI requires that publications acknowledge the UPCI CCSG support, and they are tracking compliance. If a UPCI CCSG-supported Shared Facility provided data used in your publication, please include the following statement in the acknowledgment section of your publication(s):

"This project used the UPCI [insert name(s) of shared facility(ies)] that [is/are] supported in part by award P30CA047904."

Shared Facility Directors: Please make sure to include this statement on all of your order forms, contracts, etc. as a reminder to your users to acknowledge the UPCI CCSG support.


Contact & Scheduling

The Biostatistics Facility has ongoing work on numerous projects. Thus, an investigator should allow appropriate time to complete the work requested.

For new projects, we will ordinarily need an initial meeting to discuss the project's background and some of the details relating to our involvement in it. For example, before developing the statistical section for a research grant proposal or a clinical trial, or initiating statistical analyses, we will work with the investigator to clarify the:

  • objectives of study,
  • key endpoints for analysis,
  • study design and conduct, and
  • issues to be addressed by statistical analysis.

Members of the BF have expertise in different disease sites and treatment methods. Some UPCI programs have dedicated statisticians. If you do not know the statistician specializing in your program, or your research is not included within one of the UPCI Research Programs, please contact the Director to identify a statistical collaborator.

Priorities

The BF gives highest priority to development and work on basic science, translational, therapeutic, and cancer control / population science studies having or seeking research funding from the NCI or equivalent funding agencies.

Equally important is our support of UPCI's clinical trial activities through service on its Protocol Review Committees, Data and Safety Monitoring Committee, and Clinical Research Oversight Committee.

A second tier of priorities involves development and work on investigator-initiated industry-sponsored oncology clinical trials evaluating novel therapeutic agents or treatment modalities.

Other cancer-related work intended for publication in peer-reviewed journals, such as unfunded studies based on meta-analyses, chart reviews, or various databases, is addressed on a time-available basis.

No support for non-UPCI members is provided, except for work being done in direct collaboration with a UPCI member on a cancer-related project.

Data Submission

Analyses are expedited when the data conform to the UPCI Biostatistics Submission Recommendations.

Please see the Spreadsheet Example for Response, PFS & OS.

Contact

Facility Director

Daniel P. Normolle, PhD
Associate Professor, Department of Biostatistics
Director, UPCI Biostatistics Facility
Phone: 412-383-1591
Email: dpn7@pitt.edu

Judy Hreha
Administrative Assistant
Phone: 412-383-1537
Email: jah57@pitt.edu

UPCI Biostatistics Facility

Sterling Plaza Suite 325
201 North Craig Street
Pittsburgh, PA 15213
Phone: 412-383-1537
Fax: 412-383-1535